z-logo
Premium
Allotypes of α 1 ‐antitrypsin in patients with cystic fibrosis, homozygous and heterozygous for deltaF508
Author(s) -
Döring Gerd,
KroghJohansen Helle,
Weidinger Sebastian,
Høiby Niels
Publication year - 1994
Publication title -
pediatric pulmonology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.866
H-Index - 106
eISSN - 1099-0496
pISSN - 8755-6863
DOI - 10.1002/ppul.1950180104
Subject(s) - cystic fibrosis , pseudomonas aeruginosa , medicine , heterozygote advantage , compound heterozygosity , lung , respiratory disease , carriage , serine , immunology , lung infection , mutation , microbiology and biotechnology , gastroenterology , pathology , genotype , biology , bacteria , gene , genetics , enzyme , biochemistry
In cystic fibrosis (CF) neutrophil released serine proteinase activity may facilitate Pseudomonas aeruginosa lung colonization, leading to chronic infection. Since such activity is mostly controlled by α 1 ‐antitrypsin (α 1 ‐AT), we postulated that patients with CF carrying deficient α 1 ‐AT variants might be at higher risk for P. aeruginosa acquisition and might reveal other phenomena, specific for serine proteinase activity. In 215 Danish patients with CF, homozygous (80%) or heterozygous (20%) for the major CF mutation deltaF508, α 1 ‐AT variants were determined. Carriage of deficient α‐AT variants was correlated to an earlier onset of P. aeruginosa lung infection ( P < 0.001), higher total IgG ( P < 0.001), and P. aeruginosa‐specific serum antibodies ( P < 0.0001). The two groups did not differ in lung function, probably due to intensive antimicrobial treatment. Pediatr Pulmonol. 1994; 18:3–7. © 1994 Wiley‐Liss. Inc.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom